Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Head of R&D, CMO
-
Issuer Symbol
-
SNDX on Nasdaq
Nicholas A.J. Botwood - trading volume in the past year for Syndax Pharmaceuticals Inc
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Stock Options (Right to buy) |
144,700 |
$2,956,221 |
$20.43 |
04 Feb 2026 |
Direct |
Common Stock |
|
| Common Stock |
95,165 |
$1,999,416 |
$21.01 |
04 Feb 2026 |
Direct |
|
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.